Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ALLERNIX MULTI SYMPTOM DIN 02369656

Status: Cancelled Post Market
Holder: TEVA CANADA LIMITED
Molecule: DESLORATADINE

Health Canada record

Active ingredient(s)DESLORATADINE 5 MG
Dosage formTablet
RouteOral
ScheduleNON-PRESCRIPTION DRUGS
ClassHuman
ATCR06AX27 DESLORATADINE
Original market date31-Jan-2012
Current status date11-May-2020
SourceHealth Canada DPD

Establishment licence of the holder

Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing DESLORATADINE

DINProductCompanyFormStrengthStatus
02247192AERIUSBAYER INCSyrupDESLORATADINE 0.5 MGApproved
02243919AERIUSBAYER INCTabletDESLORATADINE 5 MGMarketed
02247193AERIUS KIDSBAYER INCSyrupDESLORATADINE 0.5 MGMarketed
02309300AERIUS SINUS + ALLERGYBAYER INCTablet (Extended-Release)DESLORATADINE 2.5 MG; PSEUDOEPHEDRINE SULFATE 120 MGMarketed
02415771ALLERGY CONTROL DESLORATADINEPHARMASCIENCE INCTabletDESLORATADINE 5 MGApproved
02546019DESLORATADINEJAMP PHARMA CORPORATIONTabletDESLORATADINE 5 MGMarketed
02298155DESLORATADINE ALLERGY CONTROLPHARMASCIENCE INCTabletDESLORATADINE 5 MGMarketed
02377195AERIUS DUAL ACTION 24 HOURBAYER INCTablet (Immediate- And Extended-Release)DESLORATADINE 5 MG; PSEUDOEPHEDRINE SULFATE 240 MGCancelled Pre Market
02408740DESLORATADINE ALLERGY CONTROLDOMINION PHARMACALTabletDESLORATADINE 5 MGCancelled Post Market
02338424DESLORATADINE TABLETSAPOTEX INCTabletDESLORATADINE 5 MGDormant

Notices of Compliance

NOCDateSubmissionReason
143032013-04-17Abbreviated New Drug Submission (ANDS)Manufacturer name change
124682011-06-30Abbreviated New Drug Submission (ANDS)

International API supply for DESLORATADINE

11 valid EDQM Certificates of Suitability from 11 holders. 11 active FDA Drug Master Files.

Request a quote for ALLERNIX MULTI SYMPTOM

How to read a Canadian DIN record